Management of pregnancy in women with previous left ilio-caval stenting  by Hartung, Olivier et al.
From the American Venous Forum
Management of pregnancy in women with
previous left ilio-caval stenting
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Mourad Boufi, MD,a and Yves S. Alimi, MD, PhD,a Marseille, France
Background: Ilio-caval stenting now represents the first line treatment for disabling obstructive ilio-caval lesions. Most
patients are young women of child-bearing age. We herein report our experience of pregnancy in women who have a
history of ilio-caval stenting.
Materials and Methods: From November 1995 to April 2008, 119 patients had ilio-caval stenting for obstructive venous
disease in our department. Of these, 62 women were able to become pregnant. When pregnancy occurred, they received
preventive treatment with low molecular weight heparin (LMWH) from the 3rd month of pregnancy to 1 month after
delivery and had to wear elastic stockings. Patients also had to sleep on their right side if possible. They were followed
during the pregnancy by duplex scanning at 3, 6, and 8 months, and then 1 month after delivery.
Results: Eight pregnancies occurred in 6 patients (mean age 26.5 years) who had a patent self-expanding stent (1 patient
had 3 pregnancies). They had stenting forMay-Thurner disease in 3 patients, for post-deep venous thrombosis (DVT) left
common iliac vein occlusion in 1 patient, and during venous thrombectomy in 2 patients. All stents were self-expanding
metallic stents located on the left common iliac vein. One patient had unrelated spontaneous abortion after 2 months of
pregnancy. No DVT or symptomatic pulmonary embolism occurred during pregnancy, delivery, or during the postpar-
tum period. Four patients needed cesarean delivery and none had hemorrhagic complications. None of the patients had
adverse effects from the treatment. Duplex scan showed compression of the stent(s) at 8 months in 4 patients with inflow
obstruction in 3 patients. Postpartum duplex-scan showed no remaining stenosis in all patients. No stents had structural
damage.
Conclusion: Ilio-caval stent compression can occur during pregnancy but does not lead to structural damage to the
self-expanding stents. Despite this, no cases of DVT occurred with preventive LMWH treatment. (J Vasc Surg 2009;50:
355-9.)Although for many years surgery was the best way to
reconstruct obstructive lesions on ilio-caval segments,
stenting is nowadays the technique of choice.1 It can be
used to treat chronic lesions2,3 but also during venous
thrombectomy4,5 or thrombolysis6 for acute deep venous
thrombosis (DVT). While the long-term results of stenting
have been reported,2,3,5 there are no studies on the evolu-
tion of these stents in the venous system and they should be
considered as a foreign body that remains in a low-flow
circulation.
Regardless of the circumstances, this technique is used
on young patients andmost of them are women. Pregnancy
is thus a possibility in stented patients and it is essential that
the consequences of this condition be taken into account.
The aim of this study is to report our experience with this
condition.
MATERIALS AND METHODS
From November 1995 to April 2008, 119 consecutive
patients (median age 42 years, ranging from 16 to 79 years)
had ilio-caval stenting for obstructive venous disease in our
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chronic disabling symptoms despite accurate medical ther-
apy and 31 during venous thrombectomy for acute DVT
involving the ilio-caval segments. All patients had stenting
of the common iliac vein with extension of the stent into
the inferior vena cava (IVC) and none had stenting under
the inguinal ligament.
Ninety-one patients were women and of these 20
women were menopausal and 8 had previously had a hys-
terectomy. In addition, 1 patient had previously had a tubal
ligation. There were, therefore, 62 women capable of be-
coming pregnant.
Pregnant patients received prophylactic treatment
with Enoxeparin (Sanofi-Aventis, Paris, France), a low mo-
lecular weight heparin (LMWH), at a dose of 4000 UI
subcutaneously a day, from the 3rd month of pregnancy to
1 month after delivery with weekly platelet counts. They
also had to wear class II elastic stockings and had to sleep on
their right side if possible in order to avoid stent compres-
sion. In addition, the LMWH treatment had to be stopped
10 days before elective induction of labor or caesarean
section and was replaced with subcutaneous unfractionated
heparin.
Follow-up included clinical examination by a vascular
surgeon and duplex-scan at 3, 6, and 8 months, and then 1
month after delivery. Duplex scan was performed using a
Toshiba Powervision (Toshiba Medical System, Tokyo,
Japan) with a 3 MHz curved probe and, after 2006, a
Toshiba Aplio XG with a 2-6 MHz curved array probe and
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stent(s) was performed at 1 month after delivery. All pa-
tients had to deliver in the obstetric department of Centre
Hospitalier Universitaire Nord where they were visited by
the vascular surgeon.
RESULTS
To date, 8 patients had a pregnancy after stenting but 2
were excluded. One 24-year-old woman had venous
thrombectomy and stenting with a balloon-expandable
stent (Palmaz XXL, Cordis, Johnson & Johnson, Warren,
NJ) at 5 months of pregnancy. Despite receiving curative
anticoagulation, re-thrombosis occurred at 7months. After
delivery, radiography showed that the stent had been com-
pletely crushed.7 A Palma procedure was performed and
this reconstruction is still patent 7 years and 2 pregnancies
later. One had stenting during venous thrombectomy and
re-thrombosed 15 days after its deployment. For this rea-
son, she did not follow the protocol because pregnancy
occurred on already thrombosed stents.
The 6 remaining patients (8 pregnancies) had a median
age of 26.5 years at the onset of pregnancy (range, 22-36)
and a history of DVT in 3 patients associated with pulmo-
nary embolism in 2 patients. Two patients had a previous
pregnancy before stenting. Stenting was performed for
May-Thurner syndrome in 3 patients, for post-thrombotic
left common iliac vein thrombosis in 1 patient, and during
venous thrombectomy in 2 patients. All stents were self-
expanding metallic stents (Wallstent, Boston Scientific-
Schneider, Minneapolis, Minn) located on the left iliac
vein. Median stent length and diameter were, respectively,
60 mm (range, 40-100 mm) and 16 mm (range, 14-16).
Median delay between stenting and the first pregnancy was
33.5months (range, 14-64). In addition, 2 patients needed
iterative stenting for restenosis, respectively, 8 months and
27 months after the initial procedure (20 and 37 months
before pregnancy). Four patients were tested for thrombo-
philia before stenting and a prothrombotic state was found
in 2 patients: one factor XII deficit and one protein C
deficit. At pregnancy onset, median venous disability score
Fig 1. A 22-year-old woman who had venous thrombec
A, Stent compression at 6 months of pregnancy. B, Sten(VDS)8 was 0 (range, 0-1).The patient who had 3 pregnancies had unrelated
spontaneous abortion 2 months into her second pregnancy
(ie, before introduction of the LWMH).
Neither DVT nor symptomatic pulmonary embolism
occurred during pregnancy or delivery or during the
postpartum period. Four patients needed a cesarean
delivery and none had a hemorrhagic complication.
None of the patients had adverse effects from the treat-
ment by LMWH.
During pregnancy, all patients had worsening of their
clinical status with limb edema requiring elastic stockings
(median VDS after the 6th month: 2, range, 1-2). None
had limb or perineal varicose veins. At 3 months after
delivery, clinical status was the same as before pregnancy in
all patients.
All duplex scans were performed as scheduled. At 3
months, they were all normal. At 6 months, two cases of
stent compression were found (Fig 1) but were not associ-
ated to inflow obstruction. At 8 months, 4 compressions
were found, 3 located on the stent(s) (Fig 2) and one on the
external iliac vein proximal to the stent (Fig 3, A). In 3
patients this compression was associated with inflow
obstruction (decrease of velocity in the common femoral
vein with asymmetric flow when compared to the con-
trolateral common femoral vein and disappearance of
phasicity (Fig 3, B). These 4 patients received therapeu-
tic doses of LMWH until delivery.
Postpartum duplex scans showed no remaining stenosis
(Fig 4) and restoration of normal flow in all patients. No
stent had structural damage.
DISCUSSION
Venous thromboembolism (VTE) remains one of the
leading causes of maternal death during pregnancy in de-
veloped countries.9 It also represents an important cause of
morbidity not only during pregnancy but also in the long
term.10 The incidence of DVT is more than five times
higher during pregnancy than in age-matched non-
and stenting 14 months before the onset of pregnancy.
pression at 8 months of pregnancy.tomypregnant females ranging from 18 to 95 events per
D, Inflow obstruction with loss of phasicity.
Fig 3. External iliac vein compression at 8 months of p
pression.
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more than 1900 per 100,000 woman-years during the
postpartum period.9 Increased levels of clotting factors
(factor I, II, VII, IX, and X), together with decreased
fibrinolysis and reduced levels of the natural anticoagulant,
protein S, contribute to this state of hypercoagulability
during pregnancy. Venous stasis resulting from pressure of
the gravid uterus on the inferior vena cava and decreased
venous tone are further predisposing factors present in all
pregnant women. In addition, Macklon et al11 showed that
flow velocity decreased and vessel diameter increased in the
deep leg veins. At term, the flow velocity of the femoral vein
slowed to less than one third of the velocity recorded in the
first trimester and subsequently in the postpartum period.
DVT occurs more frequently on the left side with more
dating May-Thurner syndrome by stenting. A, Absence
ction. C, Stent compression at 8 months of pregnancy.
regnancy at duplex power (A) and color (B) scan.Fig 2. A 29-year-old woman treated 4 years before for invali
of stent compression at 6 months of pregnancy. B, No obstruFig 4. Postpartum duplex scan showing no more stent com-
than 90% of DVT in pregnancy occurring on this side.12
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of the compressive effect of the right common iliac artery
on the left common iliac vein.
Heparin, both unfractionated heparin14 or LMWH15
does not cross the placenta and is a safe anticoagulant choice
for the fetus. LMWH was shown to provide effective throm-
boprophylaxis during pregnancy.15 Antepartum prophylaxis
is recognized as an acceptable option in patients of thrombo-
philia without prior VTE and in patients with prior unpro-
voked VTE, or VTE associated with a thrombophilia.14 An-
tepartum prophylaxis can be more easily justified in women
with higher-risk thrombophilias (antithrombin deficiency,
homozygosity for factor V Leiden, or prothrombin gene
variant, persistent positivity for antiphospholipid antibodies,
or combined thrombophilias) and in those with more than
one prior event of VTE.14 The recommended regimen with
LMWH is Enoxaparin (Lovenox; Sanofi-Aventis, Paris,
France) 4000 UI subcutaneously, Dalteparin (Fragmin;
Pharmacia-Upjohn, Peapack, NJ) 5000 UI subcutane-
ously, or Tinzaparin (Innohep; Leo Pharma, St Quentin
Yvelines, France) 4500 UI subcutaneously every 24 hours
(these dosing regimens have not received Food and Drug
Administration [FDA] approval for this indication).14
Thromboprophylaxis should also be discussed regarding
the presence of the risk factors for VTE.16,17 There are no
recommendations for the duration of this prophylaxis.
Stent or external iliac vein compressionoccurred in 57%of
the pregnancies in our experience. One patient had external
iliac vein compression just proximal to the stent during her
second pregnancy, although therewas no compression during
the first. In patients with stented iliac veins, stent compression
is due to the fetus and is not related to an exaggerated
compression by the artery on the vein. Compression is depen-
dent on the position of the fetus, relating mainly to the
presence of the head of the fetus in the left part of the pelvis
which can directly compress the vein.Moreover, compression
can lead to inflow obstruction (3 patients in 4) and can be
considered an additional risk factor for DVT.
Due to the low number of patients with ilio-caval
stenting, there are no recommendations regarding throm-
boprophylaxis during pregnancy. Our attitude can be jus-
tified in patients with prior DVT or with thrombophilia (3
of our 6 patients) as suggested by the seventh ACCP
conference on antithrombotic and thrombolytic therapy.18
Thromboprophylaxis remains more controversial for pa-
tients without a history of DVT or thrombophilia who have
been stented for May-Thurner syndrome.
To date, our initial protocol has been modified. Before
stenting, women should be informed that pregnancy is possi-
ble after stenting but not recommended during the first year
while antiplatelet drugs or oral anticoagulants are given and
because most of the in-stent restenosis occur during this
period.2,3 After stenting, women who want to get pregnant
should have testing for thrombophilia and a Duplex scan in
order to check for restenosis. Once pregnant, a Duplex scan
should be performed at 3, 6, and 8 months of pregnancy and
at 1 month after delivery. Thromboprophylaxis is performed
using LMWH from the 3rd month of pregnancy to 1 monthafter delivery, but in case of significant compression (with
venous obstruction), a therapeutic dose of LMWH should be
used. This type of compression almost certainly represents a
higher risk of femoro-iliac thrombosis.
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